Real-time enrollment status for this human metapneumovirus infection clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 5:34 PM UTC
| NCT Number | NCT07824622 |
| Recruiting Status | Recruiting |
| Condition | Human Metapneumovirus Infection |
| Phase | PHASE1 |
| Target Enrollment | 144 participants |
| Active Locations | 2 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | September 17, 2026 (Sep 17, 2026) |
As of October 17, 2026: Clinical trial NCT07824622 is currently recruiting participants. This phase1 study for human metapneumovirus infection is actively seeking new participants at 2 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07824622 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07824622 was last updated Sep 17, 2026 (September 17, 2026). HelloStudys verifies this status automatically.